In 2014, the FDA accepted a formulation of hydrocodone known as Zohydro ER produced by Zogenix Prescribed drugs. The approval of Zohydro ER was controversial, on account of worries in excess of its potential for compound abuse. The FDA accepted Zohydro ER over the objections of its personal review panel, http://anthonyf517cgd6.blog4youth.com/profile